President Biden's proposal to cover obesity treatments could boost Novo Nordisk and Eli Lilly shares.

Shares of Novo Nordisk and Eli Lilly rose after President Biden proposed including obesity treatments under healthcare coverage. This move could increase access to medications and therapies for obesity, benefiting these pharmaceutical companies whose products are used in obesity treatment.

November 26, 2024
4 Articles